Tumor‐Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti‐FGF23 Monoclonal Antibody
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4280
Abstract: I n this issue of JBMR, Jan de Beur and colleagues (1) report the primary analysis and findings up to closure of their prospective, open-label, single-arm, phase 2 study (NCT02304367) to evaluate the safety and… read more here.
Keywords: treatment; tumor induced; tio; induced osteomalacia ... See more keywords
Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor‐Induced Osteomalacia: Outcome of a Retrospective Surveillance
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4620
Abstract: Tumor‐induced osteomalacia (TIO) is an acquired fibroblast growth factor 23 (FGF23)‐related hypophosphatemic osteomalacia caused by phosphaturic mesenchymal tumors (PMTs) developed in the bone or soft tissue. Diagnostic delay should be addressed, and ideal techniques to… read more here.
Keywords: tumor induced; tomography; induced osteomalacia; treatment ... See more keywords
Tumor-induced osteomalacia in association with PTEN-negative Cowden syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Osteoporosis International"
DOI: 10.1007/s00198-017-4372-x
Abstract: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic condition in which phosphaturic mesenchymal tumors (PMTs) secrete high levels of fibroblast growth factor 23 (FGF23) into the circulation. This results in renal phosphate wasting, hypophosphatemia, muscle weakness,… read more here.
Keywords: cowden syndrome; tumor induced; tio; induced osteomalacia ... See more keywords
Clinical characteristics and surgical outcomes of vertebral lesions associated with tumor-induced osteomalacia: report of 16 patients and review of the literature
Sign Up to like & getrecommendations! Published in 2024 at "Osteoporosis International"
DOI: 10.1007/s00198-024-07178-2
Abstract: Vertebral tumors in patients with tumor-induced osteomalacia (TIO) have a low diagnostic rate and poor postoperative outcomes. The application of 68 Ga-DOTATATE-PET/CT significantly increased the detection rate. Compared with tumor curettage, segmental resection was recommended… read more here.
Keywords: induced osteomalacia; tumor; tio patients; vertebral tio ... See more keywords
Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia
Sign Up to like & getrecommendations! Published in 2025 at "Osteoporosis International"
DOI: 10.1007/s00198-025-07469-2
Abstract: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by excess fibroblast growth factor 23 (FGF23), leading to hypophosphatemia and osteomalacia. It typically manifests in adulthood, with pediatric cases being exceedingly rare. Early diagnosis is… read more here.
Keywords: induced osteomalacia; pediatric onset; tumor; case ... See more keywords
Tumor-Induced Osteomalacia
Sign Up to like & getrecommendations! Published in 2020 at "Calcified Tissue International"
DOI: 10.1007/s00223-020-00691-6
Abstract: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by tumoral production of fibroblast growth factor 23 (FGF23). The hallmark biochemical features include hypophosphatemia due to renal phosphate wasting, inappropriately normal or frankly low 1,25-dihydroxy-vitamin… read more here.
Keywords: fgf23; tumor induced; tio; induced osteomalacia ... See more keywords
Epidemiology of Tumor-Induced Osteomalacia in Denmark
Sign Up to like & getrecommendations! Published in 2021 at "Calcified Tissue International"
DOI: 10.1007/s00223-021-00843-2
Abstract: Tumor-induced osteomalacia (TIO) is a rare, acquired condition of phosphate wasting due to phosphaturic mesenchymal tumors. Because the incidence and prevalence of TIO is unknown, we conducted an observational cohort study using national Danish health… read more here.
Keywords: per 100; 100 000; tumor induced; tio ... See more keywords
Treatment Advances in Tumor-Induced Osteomalacia
Sign Up to like & getrecommendations! Published in 2025 at "Calcified Tissue International"
DOI: 10.1007/s00223-024-01317-x
Abstract: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by hypersecretion of fibroblast growth factor 23 (FGF23) by typically benign phosphaturic mesenchymal tumors (PMTs). FGF23 excess causes chronic hypophosphatemia through renal phosphate losses and decreased… read more here.
Keywords: induced osteomalacia; therapy; treatment advances; tumor ... See more keywords
Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms
Sign Up to like & getrecommendations! Published in 2021 at "Head and Neck Pathology"
DOI: 10.1007/s12105-020-01267-4
Abstract: Tumor induced osteomalacia (TIO) is a rare paraneoplastic syndrome associated with tumors secreting fibroblast growth factor 23, which induces osteomalacia. Microscopically, these tumors most commonly show benign phosphaturic mesenchymal tumors. We report the first case… read more here.
Keywords: case; tumor induced; oral neoplasms; induced osteomalacia ... See more keywords
Extended Whole-body Ga-68 DOTATATE PET-CT in evaluating Tumour-Induced Osteomalacia: Case report and review of literature
Sign Up to like & getrecommendations! Published in 2021 at "Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s13139-021-00695-6
Abstract: Tumour-induced osteomalacia is a rare paraneoplastic syndrome that manifests as chronic hypophosphataemia, non-specific bone pain and muscle weakness. It is generally caused by phosphaturic mesenchymal tumour (PMT), which is uncommonly associated with synchronous tumours. However,… read more here.
Keywords: extended whole; dotatate pet; disease; induced osteomalacia ... See more keywords
Extended curettage for tumour-induced osteomalacia in the bone.
Sign Up to like & getrecommendations! Published in 2024 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyad180
Abstract: BACKGROUND extended curettage is generally used to treat infiltrative bone tumours. However, the extent of the curettage performed in previous studies remains unclear. This study aimed to investigate the efficacy of extended curettage for bone… read more here.
Keywords: curettage; tumour induced; bone; induced osteomalacia ... See more keywords